Zhihua Sun

NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/mTOR phosphorylation

Gang Wu, Jing Chen, Yu Chang, 2015, OncoTargets and therapy.

Temozolomide plus rituximab for elderly with relapsed primary central nervous system lymphoma

Gang Wu, Jinghua Ren, Qingfen Li, 2011 .

Sp1 inhibition-mediated upregulation of VEGF165b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549

Jing Chen, Gang Peng, Sheng Zhang, 2011, Tumor Biology.

NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOr phosphorylation

Yung-Chun Chang, Jing Chen, Jinghua Ren, 2015 .

NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOr phosphorylation

Yung-Chun Chang, Jing Chen, Jinghua Ren, 2015 .

NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOr phosphorylation

Yung-Chun Chang, Jing Chen, Jinghua Ren, 2015 .

NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOr phosphorylation

Yung-Chun Chang, Jing Chen, Jinghua Ren, 2015 .